| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |